BGP-31646

N/A

Report date: 2026/01/19 17:01:30
NMEFirst In Class

Base Information

Drug NameBGP-31646
Drug Alias NameBGP-31646BGP31646
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSolute carrier family 15 member 4 inhibitors
TargetsSolute carrier family 15 member 4
Therapy Area/IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBridGene Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesBridGene Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A